{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By JACKIE CALMES", "person": [{"rank": 1, "role": "reported", "firstname": "Jackie", "organization": "", "lastname": "CALMES"}]}, "abstract": "Pfizer's purchase of Ireland-based Allergan to avoid American taxes by reincorporating there provokes negative reaction from lawmakers in both parties; several calls are made for tax revision, though similar appeals have been made in past without action.", "type_of_material": "News", "word_count": "1053", "lead_paragraph": "The blockbuster pharmaceutical merger has put new pressure on Congress and the White House to overhaul the corporate tax code.", "pub_date": "2015-11-24T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Pfizer-Allergan Merger Reignites Tax Reform Discussion", "print_headline": "Drug Merger Reignites Tax Reform Discussion"}, "snippet": "The blockbuster pharmaceutical merger has put new pressure on Congress and the White House to overhaul the corporate tax code.", "multimedia": [{"height": 126, "url": "images/2015/11/24/business/24corptax-web1/24corptax-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/11/24/business/24corptax-web1/24corptax-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/11/24/business/24corptax-web1/24corptax-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/11/24/business/24corptax-web1/24corptax-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/11/24/business/24corptax-web1/24corptax-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/11/24/business/24corptax-web1/24corptax-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/24/business/drug-merger-reignites-tax-reform-discussion.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Pfizer Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Allergan Inc", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Corporate Taxes", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Tax Shelters", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "United States Politics and Government", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Relocation of Business", "name": "subject"}, {"rank": "8", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "9", "is_major": "N", "value": "Federal Taxes (US)", "name": "subject"}], "blog": [], "_id": "5653c97638f0d858aca89c50", "source": "The New York Times"}